The present invention is directed to compounds of Formula I: ##STR00001## which are modulators of chemokine receptors. The compounds of the invention, and compositions thereof, are useful in the treatment of diseases related to chemokine receptor expression and/or activity.

 
Web www.patentalert.com

< Compositions and kits for detecting pathogen infection

> Compositions useful as inhibitors of protein kinases

> 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

~ 00598